4004 ESC Guidelines label use of medication should be limited to situations where it is in
the patient's interest to do so, with regard to the quality, safety, and efficacy of care, and only …

for digital applications (smartphones, etc.). These versions are abridged and thus, for more
detailed information, the user should always access to the full text version of the guidelines …

The recent advances in technology combined with the need to manage patients remotely
during the coronavirus disease-19 (COVID-19) pandemic, have led to a rapid adaptation of …

The use of substances and medications with potential cardiovascular effects among those
practicing sports and physical activity has progressively increased in recent years. This is …

This paper belongs to a series of recommendation documents for participation in leisure-
time physical activity and competitive sports by the European Association of Preventive …

There is increasing effort in both the inpatient and outpatient setting to improve care,
function, and quality of life for children with congenital heart disease, and to decrease …

Preventive cardiology encompasses the whole spectrum of cardiovascular disease (CVD)
prevention, at individual and population level, through all stages of life. This includes …

Endurance athletes have a high prevalence of atrial fibrillation (AF), probably caused by
exercise-induced cardiac remodelling. Athletes diagnosed with AF are often advised to …

Introduction Catecholaminergic polymorphic ventricular tachycardia (CPVT) is a cardiac
inherited arrhythmogenic disease potentially leading to sudden cardiac death that is …

Objective to evaluate the prevalence of cardiac involvement after COVID-19 in competitive
athletes at return-to-play (RTP) evaluation, following the recommended Italian protocol …